196 related articles for article (PubMed ID: 29563635)
21. Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma.
Suzuki T; Nakata T; Miki Y; Kaneko C; Moriya T; Ishida T; Akinaga S; Hirakawa H; Kimura M; Sasano H
Cancer Res; 2003 Jun; 63(11):2762-70. PubMed ID: 12782580
[TBL] [Abstract][Full Text] [Related]
22. Intratumoral androgen metabolism and actions in invasive lobular carcinoma of the breast.
Yoda T; McNamara KM; Miki Y; Takagi M; Rai Y; Ohi Y; Sagara Y; Tamaki K; Hirakawa H; Ishida T; Suzuki T; Ohuchi N; Sasano H
Cancer Sci; 2014 Nov; 105(11):1503-9. PubMed ID: 25230018
[TBL] [Abstract][Full Text] [Related]
23. Effect of tamoxifen or anastrozole on steroid sulfatase activity and serum androgen concentrations in postmenopausal women with breast cancer.
Stanway SJ; Palmieri C; Stanczyk FZ; Folkerd EJ; Dowsett M; Ward R; Coombes RC; Reed MJ; Purohit A
Anticancer Res; 2011 Apr; 31(4):1367-72. PubMed ID: 21508387
[TBL] [Abstract][Full Text] [Related]
24. Oestrogen and colorectal cancer: mechanisms and controversies.
Foster PA
Int J Colorectal Dis; 2013 Jun; 28(6):737-49. PubMed ID: 23319136
[TBL] [Abstract][Full Text] [Related]
25. Steroid sulfatase and estrogen sulfotransferase in colon carcinoma: regulators of intratumoral estrogen concentrations and potent prognostic factors.
Sato R; Suzuki T; Katayose Y; Miura K; Shiiba K; Tateno H; Miki Y; Akahira J; Kamogawa Y; Nagasaki S; Yamamoto K; Ii T; Egawa S; Evans DB; Unno M; Sasano H
Cancer Res; 2009 Feb; 69(3):914-22. PubMed ID: 19141651
[TBL] [Abstract][Full Text] [Related]
26. Constitutive expression of the steroid sulfatase gene supports the growth of MCF-7 human breast cancer cells in vitro and in vivo.
James MR; Skaar TC; Lee RY; MacPherson A; Zwiebel JA; Ahluwalia BS; Ampy F; Clarke R
Endocrinology; 2001 Apr; 142(4):1497-505. PubMed ID: 11250930
[TBL] [Abstract][Full Text] [Related]
27. Steroid sulfatase inhibitors: promising new tools for breast cancer therapy?
Geisler J; Sasano H; Chen S; Purohit A
J Steroid Biochem Mol Biol; 2011 May; 125(1-2):39-45. PubMed ID: 21356310
[TBL] [Abstract][Full Text] [Related]
28. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
Smuc T; Rizner TL
Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
[TBL] [Abstract][Full Text] [Related]
29. Steroid sulfatase inhibition success and limitation in breast cancer clinical assays: An underlying mechanism.
Sang X; Han H; Poirier D; Lin SX
J Steroid Biochem Mol Biol; 2018 Oct; 183():80-93. PubMed ID: 29803725
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
Sanpaolo P; Barbieri V; Genovesi D
Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
[TBL] [Abstract][Full Text] [Related]
31. Phase I study of STX 64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitor.
Stanway SJ; Purohit A; Woo LW; Sufi S; Vigushin D; Ward R; Wilson RH; Stanczyk FZ; Dobbs N; Kulinskaya E; Elliott M; Potter BV; Reed MJ; Coombes RC
Clin Cancer Res; 2006 Mar; 12(5):1585-92. PubMed ID: 16533785
[TBL] [Abstract][Full Text] [Related]
32. Steroid sulphatase and oestrogen sulphotransferase in human non-small-cell lung carcinoma.
Iida S; Kakinuma H; Miki Y; Abe K; Sakurai M; Suzuki S; Niikawa H; Akahira J; Suzuki T; Sasano H
Br J Cancer; 2013 Apr; 108(7):1415-24. PubMed ID: 23531699
[TBL] [Abstract][Full Text] [Related]
33. Oestrogen-synthesising enzymes and breast cancer.
Kulendran M; Salhab M; Mokbel K
Anticancer Res; 2009 Apr; 29(4):1095-109. PubMed ID: 19414351
[TBL] [Abstract][Full Text] [Related]
34. The Role of Steroid Sulfatase as a Prognostic Factor in Patients with Endometrial Cancer.
Lee WM; Jang KS; Bae J; Koh AR
Yonsei Med J; 2016 May; 57(3):754-60. PubMed ID: 26996578
[TBL] [Abstract][Full Text] [Related]
35. In vitro interactions between mammary fibroblasts (Hs 578Bst) and cancer epithelial cells (MCF-7) modulate aromatase, steroid sulfatase and 17β-hydroxysteroid dehydrogenases.
Wang X; Sang X; Diorio C; Lin SX; Doillon CJ
Mol Cell Endocrinol; 2015 Sep; 412():339-48. PubMed ID: 26044867
[TBL] [Abstract][Full Text] [Related]
36. Expression level of enzymes related to in situ estrogen synthesis and clinicopathological parameters in breast cancer patients.
Suzuki M; Ishida H; Shiotsu Y; Nakata T; Akinaga S; Takashima S; Utsumi T; Saeki T; Harada N
J Steroid Biochem Mol Biol; 2009 Feb; 113(3-5):195-201. PubMed ID: 19159687
[TBL] [Abstract][Full Text] [Related]
37. Correlation of body mass index and menopausal status with the intra-tumoral estrogen system in invasive breast cancer.
Pfeiler G; Treeck O; Wenzel G; Goerse R; Hartmann A; Schmitz G; Ortmann O
Gynecol Endocrinol; 2009 Mar; 25(3):183-7. PubMed ID: 19347708
[TBL] [Abstract][Full Text] [Related]
38. Steroid sulfatase inhibitors: promising new therapy for breast cancer.
Sadozai H
J Pak Med Assoc; 2013 Apr; 63(4):509-15. PubMed ID: 23905452
[TBL] [Abstract][Full Text] [Related]
39. Intratumoral concentration of sex steroids and expression of sex steroid-producing enzymes in ductal carcinoma in situ of human breast.
Shibuya R; Suzuki T; Miki Y; Yoshida K; Moriya T; Ono K; Akahira J; Ishida T; Hirakawa H; Evans DB; Sasano H
Endocr Relat Cancer; 2008 Mar; 15(1):113-24. PubMed ID: 18310280
[TBL] [Abstract][Full Text] [Related]
40. Induction of steroid sulfatase expression in PC-3 human prostate cancer cells by insulin-like growth factor II.
Sung CH; Im HJ; Park N; Kwon Y; Shin S; Ye DJ; Cho NH; Park YS; Choi HK; Kim D; Chun YJ
Toxicol Lett; 2013 Nov; 223(2):109-15. PubMed ID: 24055520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]